Phosphorylated Codonopsis pilosula polysaccharide could inhibit the virulence of duck hepatitis A virus compared with Codonopsis pilosula polysaccharide

International Journal of Biological Macromolecules

Volumn 94, Issue , 2017, Pages 28-35

  Ming, Ke ^a   Chen, Yun ^a   Yao, Fangke ^a   Shi, Jintong ^a   Yang, Jingjing ^a   Du, Hongxu ^a   Wang, Xunyi ^b   Wang, Yixuan ^a   Liu, Jiaguo ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antiviral activity; Codonopsis pilosula polysaccharide; Duck hepatitis A virus; IFN ; Phosphorylated modification

Indexed keywords

ANTIVIRUS AGENT; BETA INTERFERON; CODONOPSIS PILOSULA POLYSACCHARIDE; PHOSPHORYLATED CODONOPSIS PILOSULA POLYSACCHARIDE; POLYSACCHARIDE; UNCLASSIFIED DRUG; AVIAN PROTEIN; PLANT EXTRACT;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DUCK; DUCK HEPATITIS A VIRUS; EMBRYO; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HEPATITIS A VIRUS; INFRARED SPECTROSCOPY; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STRUCTURE ANALYSIS; SURVIVAL RATE; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; CELL CULTURE; CHEMISTRY; CODONOPSIS; DRUG EFFECTS; DUCK HEPATITIS B VIRUS; HEPATITIS, VIRAL, ANIMAL; LIVER CELL; METABOLISM; PHYSIOLOGY; POULTRY DISEASES; PRECLINICAL STUDY; VIROLOGY; VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; AVIAN PROTEINS; CELLS, CULTURED; CODONOPSIS; DRUG EVALUATION, PRECLINICAL; DUCKS; HEPATITIS VIRUS, DUCK; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; INTERFERON-BETA; PLANT EXTRACTS; POLYSACCHARIDES; POULTRY DISEASES; VIRULENCE; VIRUS REPLICATION;

EID: 84989933905     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2016.10.002     Document Type: Article

References (39)

1. [1] Levine, P.P., Fabricant, J., A hitherto-undescribed virus disease of ducks in North America. J. Cornell Vet. 40 (1950), 71–86.
2. [2] Toth, T., Studies of an agent causing mortality among ducklings immune to duck virus hepatitis. Avian Dis. 13 (1969), 834–846.
3. [3] Pan, M., Yang, X.R., Zhou, L., Ge, X.N., Guo, X., Liu, J.H., Zhang, D.B., Yang, H.C., Duck hepatitis A virus possesses a distinct type IV internal ribosome entry site element of picornavirus. J. Virol. 86 (2012), 1129–1144.
4. [4] Tseng, C.H., Knowles, N.J., Tsai, H.J., Molecular analysis of duck hepatitis virus type 1 indicates that it should be assigned to a new genus. Virus Res. 123 (2007), 190–203.
5. [5] Fu, Y.Z., Chen, Z.Y., Li, C.F., Liu, G.Q., Protective immune responses in ducklings induced by a suicidal DNA vaccine of the VP1 gene of duck hepatitis virus type 1. Vet. Microbiol. 160 (2012), 314–318.
6. [6] Sun, Y.X., Liu, J.C., Structural characterization of a water-soluble polysaccharide from the roots of Codonopsis pilosula and its immunity activity. Int. J. Biol. Macromol. 43 (2008), 279–282.
7. [7] Liu, G.Z., Cai, D.G., Shao, S., Studies on the chemical constituents and pharmacological actions of dangshen, Codonopsis pilosula (Franch.) Nannf. J. Tradit. Chin. Med. 8 (1988), 41–47.
8. [8] Luo, H., Lin, S., Ren, F., Wu, L., Chen, L., Sun, Y., Antioxidant and antimicrobial capacity of Chinese medicinal herb extracts in raw sheep meat. J. Food Prot. 70 (2007), 1440–1445.
9. [9] Shan, B.E., Yoshida, Y., Sugiura, T., Yamashita, U., Stimulating activity of Chinese medicinal herbs on human lymphocytes in vitro. Int. J. Immunopharma 21 (1999), 149–154.
10. [10] Liu, X.X., Wan, Z.J., Shi, L., Lu, X.X., Preparation and antiherpetic activities of chemically modified polysaccharides from Polygonatum cyrtonema Hua. Carbohydr. Polym. 83 (2011), 737–742.
11. [11] Chen, X., Xu, X., Zhang, L., Zeng, F., Chain conformation and anti-tumor activities of phosphorylated (1 → 3)-β-d-glucan from Poria cocos. Carbohydr. Polym. 78 (2009), 581–587.
12. [12] Wu, Q., Dai, Y.G., Phosphate of alkali-soluble tremella polysaccharide from tremella fuciformisu. Food Sci. Technol. 35 (2010), 75–77.
13. [13] Xiong, W., Chen, Y., Wang, Y., Liu, J.G., Roles of the antioxidant properties of icariin and its phosphorylated derivative in the protection against duck virus hepatitis. BMC Vet. Res., 10, 2014, 226.
14. [14] Pestka, S., Langer, J.A., Zoon, K.C., Samuel, C.E., Interferons and their actions. Annu. Rev. Biochem. 56 (1987), 727–777.
15. [15] Havell, E.A., Berman, B., Ogburn, C.A., Berg, K., Paucker, K., Vilcek, J., Two antigenically distinct species of human interferon. Proc. Natl. Acad. Sci. U. S. A. 72 (1975), 2185–2187.
16. [16] Haller, O., Kochs, G., Weber, F., The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 (2006), 119–130.
17. [17] Chen, Y., Xiong, W., Zeng, L., Wang, D.Y., Wu, Y., Hu, Y.L., Liu, J.G., Comparison of Bush Sophora Root polysaccharide and its sulfate's anti-duck hepatitis A virus activity and mechanism. Carbohydr. Polym. 102 (2014), 333–340.
18. [18] Hsieh, C.Y., Hsu, T.H., Yang, F.C., Production of polysaccharides of Ganoderma lucidum (CCRC36021) by reusing thin stillage. Process Biochem. 40 (2005), 909–916.
19. [19] Lowry, O.H., Roberts, N.R., Leiner, K.Y., Wu, M.L., Farr, A.L., The quantitative histochemistry of brain 1. chemicalmethods. J. Biol. Chem. 207 (1954), 1–17.
20. [20] Qin, T., Chen, J., Wang, D.Y., Hu, Y.L., Wang, M., Zhang, J., Optimization of selenylation conditions for Chinese angelica polysaccharide based on immune-enhancing activity. Carbohydr. Polym. 92 (2013), 645–650.
21. [21] Zhang, Y.Q., Sun, Z.A., Liu, J.G., Wang, D.Y., Zhang, B.K., Flavone ingredients can synergistically inhibit NDV infecting cell and improve ND vaccine's protective rate. Int. J. Biol. Macromol. 51 (2012), 201–208.
22. [22] Chen, Y., Wu, Y., Xian, L.T., Song, M.Y., Zeng, L., Xiong, W., Liu, J.G., Effects of Bush Sophora Root polysaccharide and its sulfate on immuno-enhancing of the therapeutic DVH. Int. J. Biol. Macromol. 80 (2015), 217–224.
23. −ΔΔCT method. Methods 25 (2001), 402–408.
24. [24] Marcottea, L., Kegelaera, G., Sandta, C., Barbeaub, J., Lafleur, M., An alternative infrared spectroscopy assay for the quantification of polysaccharides in bacterial samples. Anal. Biochem. 1 (2007), 7–14.
25. [25] Boulet, J.C., Williams, P., Doco, T., A Fourier transform infrared spectroscopy study of wine polysaccharides. Carbohydr. Polym. 1 (2007), 79–85.
26. [26] Verma, A., Prasad, K.N., Singh, A.K., Nyati, K.K., Gupta, R.K., Paliwal, V.K., Evaluation of the MTT lymphocyte proliferation assay for the diagnosis of neurocysticercosis. J. Microbiol. Methods 81 (2010), 175–178.
27. [27] Burleson, F.G., Chambers, T.M., Wiedbrauk, D.L., Virology: A Laboratory Manual. 1st edn, 1992, Academic Press, New York.
28. [28] Kumar, H., Kawai, T., Akira, S., Pathogen recognition by the innate immune system. Int. Rev. Immunol. 30 (2011), 16–34.
29. [29] Castelli, J., Hassel, B.A., Wood, K.A., Li, X.L., A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system. J. Exp. Med. 186 (1997), 967–972.
30. [30] Paulmann, D., Magulski, T., Schwarz, R., Vallbracht, A., Hepatitis A virus protein 2B suppresses beta interferon (IFN) gene transcription by interfering with IFN regulatory factor 3 activation. J. Gen. Virol. 89 (2008), 1593–1604.
31. [31] Brack, K., Berk, I., Magulski, T., Lederer, J., Dotzauer, A., Vallbracht, A., Hepatitis A virus inhibits cellular antiviral defense mechanisms induced by double-stranded RNA. J. Virol. 76 (2002), 11920–11930.
32. [32] Fensterl, V., Grotheer, D., Berk, I., Schlemminger, S., Vallbracht, A., Dotzauer, A., Hepatitis A virus suppresses RIG-I-mediated IRF-3 activation to block induction of beta interferon. J. Virol. 79 (2005), 10968–10977.
33. [33] Yao, F.K., Chen, Y., Shi, J.T., Ming, K., Liu, J.G., Replication cycle of duck hepatitis A virus type 1 in duck embryonic hepatocytes. Virology 491 (2016), 73–78.
34. [34] Vieillard, V., Lauret, E., Rousseau, V., De Maeyer, E., Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 2689–2693.
35. [35] Kornbluth, R.S., Oh, P.S., Munis, J.R., Cleveland, P.H., Richman, D.D., The role of interferons in the control of HIV replication in macrophages. Clin. Immunol. 54 (1990), 200–219.
36. [36] Coccia, E.M., Krust, B., Hovanessian, A.G., Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment. J. Biol. Chem. 269 (1994), 23087–23094.
37. [37] Shirazi, Y., Pitha, P.M., Interferon alpha-mediated inhibition of human immunodeficiency virus type 1 provirus synthesis in T-cells. Virology 193 (1993), 303–312.
38. [38] Vieillard, V., Cremer, I., Lauret, E., Rozenbaum, W., Debre, P., Autran, B., Interferon beta transduction of peripheral blood lymphocytes from HIV-infected donors increases Th1-type cytokine production and improves the proliferative response to recall antigens. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 11595–11600.
39. [39] He, H.Y., Zhou, D.J., Fan, W.P., Fu, X.L., Zhang, J., Shen, Z.G., Cyclophilin A inhibits rotavirus replication by facilitating host IFN-I production. Biochem. Biophys. Res. Commun. 422 (2012), 664–669.